ADC Therapeutics S.A. (ADCT) at a glance

ADC Therapeutics S.A. (ADCT) is a micro-cap Healthcare company. It trades at $1.02, with a -173% profit margin and revenue decline of 9.5%. It does not pay a dividend. Vestovix scores it 37/100 overall. Its strongest dimension is Safety (44/100) and its weakest is Momentum (16/100). It carries above-market volatility, so expect larger swings.

Price

$1.02

Market cap

$133.6M

P/E ratio

n/a

Dividend yield

None

Beta

1.77

52-week range

$0.78 to $4.98